Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results.

Technical innovations & patient support in radiation oncology·2025
Same author

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

European journal of cancer (Oxford, England : 1990)·2025
Same author

Dose escalation in pediatric pelvic Ewing's Sarcoma: Insights from a national treatment planning exercise.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

[Characteristics of radiotherapy for adolescents and young adults].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Radiotherapy management of paediatric cancers with synchronous metastasis.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

Posterior fossa ependymoma in children: A long-term single-center experience.

Neuro-Chirurgie·2023

Related Experiment Videos

[Predictive factors for acute radiation pneumonitis].

D Arpin1, M-A Mahé, V Servois

  • 1Service de pneumologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69317 Lyon cedex 04, France. dominique.arpin@chu-lyon.fr <dominique.arpin@chu-lyon.fr>

Revue De Pneumologie Clinique
|June 16, 2009
PubMed
Summary

Acute radiation pneumonitis (ARP) risk in lung cancer patients is primarily linked to radiation factors, not patient or tumor characteristics. Research is exploring biological markers for individual susceptibility to thoracic radiotherapy toxicity.

Related Experiment Videos

Area of Science:

  • Oncology
  • Radiotherapy
  • Pulmonology

Context:

  • Thoracic irradiation is a key treatment for nonmetastatic primary lung cancer, especially locally advanced mediastinal disease.
  • Acute radiation pneumonitis (ARP) is a significant treatment-limiting toxicity.
  • Understanding ARP risk factors is crucial for optimizing lung cancer treatment.

Purpose:

  • To review current knowledge on risk factors associated with developing acute radiation pneumonitis (ARP).
  • To identify patient, tumor, and treatment-related factors influencing ARP incidence.
  • To highlight validated predictive factors and emerging research areas for ARP.

Summary:

  • ARP incidence in non-small cell lung cancer (NSCLC) patients undergoing conventional irradiation ranges from 7-10% for moderate forms to 1-3% for severe forms.
  • Validated predictive factors for ARP are predominantly related to irradiation parameters, such as irradiated lung volumes and radiation dose.
  • While patient age over 65 is debated, other patient/tumor factors show limited predictive value for ARP.

Impact:

  • Identifies key irradiation parameters that predict ARP risk, aiding in treatment planning.
  • Underscores the need for further research into individual susceptibility and biological markers (e.g., cytokines) for predicting ARP.
  • Informs strategies to mitigate ARP, potentially improving patient outcomes in thoracic radiotherapy for lung cancer.